Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Dec;39(6):200-204.
doi: 10.18773/austprescr.2016.068. Epub 2016 Dec 5.

Long-term prescribing of new oral anticoagulants

Paul Kl Chin  1 , Matthew P Doogue  2
Affiliations
Review

Long-term prescribing of new oral anticoagulants

Paul Kl Chin et al. Aust Prescr. 2016 Dec.

Erratum in

No abstract available

Keywords: anticoagulant; apixaban; atrial fibrillation; bleeding; dabigatran; rivaroxaban; stroke; thromboembolism; warfarin.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None declared

Figures

Fig
Fig
Choosing an oral anticoagulant for long-term use
See this image and copyright information in PMC

Comment in

  • Treating patients on new anticoagulant drugs.
    Daly C. Daly C. Aust Prescr. 2016 Dec;39(6):205-207. doi: 10.18773/austprescr.2016.085. Epub 2016 Dec 5. Aust Prescr. 2016. PMID: 27996061 Free PMC article. No abstract available.
  • Treating patients on new anticoagulant drugs.
    Goh S. Goh S. Aust Prescr. 2017 Apr;40(2):46-47. doi: 10.18773/austprescr.2017.021. Epub 2017 Apr 3. Aust Prescr. 2017. PMID: 28507393 Free PMC article. No abstract available.
  • Pharmacokinetics of apixaban.
    Beirne P. Beirne P. Aust Prescr. 2017 Jun;40(3):88. doi: 10.18773/austprescr.2017.033. Epub 2017 Jun 1. Aust Prescr. 2017. PMID: 28798509 Free PMC article. No abstract available.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Chin PK. Which patients may benefit from dose adjustment of non-vitamin K antagonist oral anticoagulants? Semin Thromb Hemost 2015;41:195-207. 10.1055/s-0035-1546465 - DOI - PubMed
    1. Nutescu E, Chuatrisorn I, Hellenbart E. Drug and dietary interactions of warfarin and novel oral anticoagulants: an update. J Thromb Thrombolysis 2011;31:326-43. 10.1007/s11239-011-0561-1 - DOI - PubMed
    1. Baber U, Mastoris I, Mehran R. Balancing ischaemia and bleeding risks with novel oral anticoagulants. Nat Rev Cardiol 2014;11:693-703. 10.1038/nrcardio.2014.170 - DOI - PubMed
    1. Gonzalez Quesada CJ, Giugliano RP. Selecting an oral anticoagulant for patients with nonvalvular atrial fibrillation. J Thromb Thrombolysis 2015;39:129-38. 10.1007/s11239-014-1148-4 - DOI - PubMed
    1. Tideman PA, Tirimacco R, St John A, Roberts GW. How to manage warfarin therapy. Aust Prescr 2015;38:44-8. 10.18773/austprescr.2015.016 - DOI - PMC - PubMed

LinkOut - more resources